Atsena Therapeutics Raises $55 Million Series A Financing to Advance LCA1 Gene Therapy Clinical Program, Two Preclinical Assets, and Novel Capsid Development for Ocular Diseases

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3oWnki0
via IFTTT